The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism
Abstract
OBJECTIVES: To evaluate vascular wall structure and conduit artery stiffness in patients with primary aldosteronism. METHODS: This observational study, conducted in a University Hypertension Center, evaluated the carotid wall by 2-D ultrasonography and ultrasonic tissue characterization, and analyzed arterial stiffness by applanation tonometer. Twenty-three consecutive patients with primary aldosteronism, 24 matched patients with essential hypertension and 15 controls were studied. Intima-media thickness and corrected integrated backscatter signal of the carotid arteries were evaluated. Radial and femoral pulse wave velocity and aortic augmentation index were also investigated. RESULTS: Intima-media thickness in patients with essential hypertension (0.69 +/- 0.03 mm) was higher (P < 0.04) than that in controls (0.59 +/- 0.02 mm). This finding was more evident in primary aldosteronism patients (0.84 +/- 0.03 mm), in whom intima-media thickness was greater than that in controls (P < 0.0001) or in patients with essential hypertension (P < 0.01). Similarly, corrected integrated backscatter signal in patients with essential hypertension (-23.6 +/- 0.35 dB) was higher (P < 0.0001) than that in controls (-26.2 +/- 0.44 dB), but it was even more elevated in patients with primary aldosteronism (-22.1 +/- 0.46 dB), who showed greater corrected integrated backscatter signal than was the case in patients with essential hypertension (P < 0.009) or in controls (P < 0.0001). Femoral pulse wave velocity was higher in primary aldosteronism patients (10.8 +/- 0.57 m/s) than in patients with essential hypertension (9.1 +/- 0.34 m/s, P < 0.03) or in controls (7.1 +/- 0.51 m/s, P < 0.0001). Femoral pulse wave velocity was lower in controls than in patients with essential hypertension (P < 0.0001). The same pattern was observed for radial pulse wave velocity. Aortic augmentation index was higher in primary aldosteronism patients (28.2 +/- 2.1%) than in patients with essential hypertension (26.0 +/- 1.8%) or in controls (16.8 +/- 2.0%, P < 0.001). Patients with essential hypertension likewise exhibited higher aortic augmentation index than controls (P < 0.001). CONCLUSION: Aldosterone excess is responsible per se for vascular morphological (wall thickening and carotid artery fibrosis) and functional (central stiffness) damage.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Primary aldosteronism is also associated with left ventricular hypertrophy, diastolic dysfunction and heart failure, large artery stiffness, oxidative stress, widespread tissue inflammation and fibrosis, and increased resistance vessel remodeling compared with primary hypertension.291–293”
From Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association (2018) · cites this paper as [292]
Citations
Cites
1 retracted
Aldosterone Directly Induces Myocyte Apoptosis Through Calcineurin-Dependent Pathways
Mano, A., Tatsumi, T., Shiraishi, J., Keira, N., Nomura, T., Takeda, M., Nishikawa, S., Yamanaka, S., Matoba, S., Kobara, M., et al. (2004) · Circulation · doi:10.1161/01.cir.0000135599.33787.ca · Cited by 95
RetractedExpert consensus document on arterial stiffness: methodological issues and clinical applications
Laurent, S., Cockcroft, J., Van Bortel, L., Boutouyrie, P., Giannattasio, C., Hayoz, D., Pannier, B., Vlachopoulos, C., Wilkinson, I., Struijker-Boudier, H., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl254 · Cited by 6,077
2007 Guidelines for the Management of Arterial Hypertension
Mancia, G., Backer, G. D., Dominiczak, A. F., Cífková, R., Fagard, R. H., Germanò, G., Grassi, G. M., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,870
Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging.
Pignoli, P., Tremoli, E., Poli, A., Oreste, P., & Paoletti, R. (1986) · Circulation · doi:10.1161/01.cir.74.6.1399 · Cited by 2,404
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism
Milliez, P., Girerd, X. J., Plouin, P., Blacher, J., Safar, M. E., & Mourad, J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.01.015 · Cited by 1,541
Chen, C.-H., Nevo, E., Fetics, B., Pak, P. H., Yin, F. C. P., Maughan, W. L., & Kass, D. A. (1997) · Circulation · doi:10.1161/01.cir.95.7.1827 · Cited by 1,307
Vascular Remodeling in Hypertension: Roles of Apoptosis, Inflammation, and Fibrosis
Intengan, H. D., & Schiffrin, E. L. (2001) · Hypertension · doi:10.1161/hy09t1.096249 · Cited by 979
Structure and Mechanical Properties of Resistance Arteries in Hypertension
Intengan, H. D., & Schiffrin, E. L. (2000) · Hypertension · doi:10.1161/01.hyp.36.3.312 · Cited by 471
Structure-dependent dynamic mechanical behavior of fibrous caps from human atherosclerotic plaques.
Lee, R. T., Grodzinsky, A. J., Frank, E. H., Kamm, R. D., & Schöen, F. J. (1991) · Circulation · doi:10.1161/01.cir.83.5.1764 · Cited by 372
Mechanisms of Mineralocorticoid Action
Fuller, P. J., & Young, M. J. (2005) · Hypertension · doi:10.1161/01.hyp.0000193502.77417.17 · Cited by 324
Cited by
Sorted by citations
Funder, J. W., Carey, R. M., Mantero, F., Murad, M. H., Reincke, M., Shibata, H., Stowasser, M., & Young, W. F. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-4061 · Cited by 2,925
Carey, R. M., Calhoun, D. A., Bakris, G. L., Brook, R. D., Daugherty, S. L., Dennison-Himmelfarb, C. R., Egan, B. M., Flack, J. M., Gidding, S. S., Judd, E., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000084 · Cited by 1,153
Vascular Smooth Muscle Cells and Arterial Stiffening: Relevance in Development, Aging, and Disease
Lacolley, P. J., Regnault, V., Segers, P., & Laurent, S. (2017) · Physiological Reviews · doi:10.1152/physrev.00003.2017 · Cited by 763
Diagnosis and treatment of primary aldosteronism
Reincke, M., Bancos, I., Mulatero, P., Scholl, U. I., Stowasser, M., & Williams, T. A. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00210-2 · Cited by 377
Vascular Smooth Muscle Remodeling in Conductive and Resistance Arteries in Hypertension
Brown, I. A. M., Diederich, L., Good, M. E., DeLalio, L. J., Murphy, S. A., Cortese-Krott, M. M., Hall, J. L., Le, T. H., & Isakson, B. E. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311229 · Cited by 277
Mineralocorticoid receptors in vascular function and disease
McCurley, A., & Jaffe, I. Z. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.06.014 · Cited by 191
Stowasser, M., & Gordon, R. D. (2016) · Physiological Reviews · doi:10.1152/physrev.00026.2015 · Cited by 162
DeMarco, V. G., Habibi, J., Jia, G., Aroor, A. R., Ramirez‐Perez, F. I., Martinez‐Lemus, L. A., Bender, S. B., Garro, M., Hayden, M. R., Sun, Z., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05674 · Cited by 151
Primary Aldosteronism: State-of-the-Art Review
Vaidya, A., Hundemer, G. L., Nanba, K., Parksook, W. W., & Brown, J. M. (2022) · American Journal of Hypertension · doi:10.1093/ajh/hpac079 · Cited by 135
Diagnosis and management of primary aldosteronism: An updated review
Chao, C., Wu, V., Kuo, C., Lin, Y., Chang, C., Chueh, S., Wu, K., Pimenta, E., & Stowasser, M. (2013) · Annals of Medicine · doi:10.3109/07853890.2013.785234 · Cited by 128
Update in Primary Aldosteronism
Stowasser, M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3663 · Cited by 126
Galmiche, G., Pizard, A., Gueret, A., Moghrabi, S. E., Ouvrard‐Pascaud, A., Berger, S., Challande, P., Jaffe, I. Z., Labat, C., Lacolley, P. J., et al. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01967 · Cited by 124
Emerging Concepts in the Molecular Basis of Pulmonary Arterial Hypertension
Maron, B. A., & Leopold, J. A. (2015) · Circulation · doi:10.1161/circulationaha.114.006980 · Cited by 106
Parasiliti‐Caprino, M., Lopez, C., Prencipe, N., Lucatello, B. G., Settanni, F., Giraudo, G., Rossato, D., Mengozzi, G., Ghigo, E., Benso, A. S., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002441 · Cited by 105
Lin, Y., Lin, L., Chen, A., Wu, X.-M., Lee, J., Su, T., Wu, V., Chueh, S., Lin, W., Lo, M., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.12.003 · Cited by 101
Serum Aldosterone Concentration, Blood Pressure, and Coronary Artery Calcium
Inoue, K., Goldwater, D. S., Allison, M., Seeman, T. E., Kestenbaum, B. R., & Watson, K. E. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15006 · Cited by 91
Update in Primary Aldosteronism
Stowasser, M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1399 · Cited by 89
Laboratory challenges in primary aldosteronism screening and diagnosis
Rehan, M., Raizman, J. E., Cavalier, E., Don-Wauchope, A. C., & Holmes, D. T. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.01.003 · Cited by 89
Wu, V., Lo, S., Chen, Y., Huang, P., Tsai, C., Liang, C., Kuo, C.-C., Kuo, Y.-S., Lee, B., Wu, E., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1135 · Cited by 86
Smooth Muscle Cell–Mineralocorticoid Receptor as a Mediator of Cardiovascular Stiffness With Aging
Kim, S. K., McCurley, A., DuPont, J. J., Aronovitz, M. A., Moss, M. E., Stillman, I. E., Karumanchi, S. A., Christou, D. D., & Jaffe, I. Z. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.10437 · Cited by 84
Chen, S.-Y., Chen, J., Huang, W., Puar, T. H. K., Kek, P. C., Chueh, S., Lin, Y., Wu, V., & TAIPAI Study Group (2022) · European Journal of Endocrinology · doi:10.1530/eje-22-0375 · Cited by 74
Endothelial Dysfunction in Primary Aldosteronism
Chen, Z., Tsai, C., Pan, C., Chou, C., Liao, C., Hung, C., Wu, V., Lin, Y., & TAIPAI Study Group (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205214 · Cited by 74
Wohlin, M., Sundström, J., Andrén, B., Larsson, A. O., & Lind, L. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.01.032 · Cited by 73
Studying the Effects of Matrix Stiffness on Cellular Function using Acrylamide-based Hydrogels
Cretu, A., Castagnino, P. A., & Assoian, R. K. (2010) · Journal of Visualized Experiments · doi:10.3791/2089 · Cited by 69
Resistant Hypertension and Aldosterone: An Update
Clark, D., Ahmed, M. I., & Calhoun, D. A. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2012.03.010 · Cited by 54
Primary Aldosteronism and Resistant Hypertension: A Pathophysiological Insight
Bioletto, F., Bollati, M., Lopez, C., Arata, S., Procopio, M., Ponzetto, F., Ghigo, E., Maccario, M., & Parasiliti‐Caprino, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094803 · Cited by 55
Rezai, M. R., Wallace, A. M., Sattar, N. A., Finn, J. D., Wu, F. C. W., & Cruickshank, J. K. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.174425 · Cited by 55
Li, W., Chen, X., Riley, A. M., Hiett, S. C., Temm, C. J., Beli, E., Long, X., Chakraborty, S., Alloosh, M., White, F. A., et al. (2017) · Basic Research in Cardiology · doi:10.1007/s00395-017-0643-0 · Cited by 50
McCurley, A., McGraw, A. P., Pruthi, D., & Jaffe, I. Z. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1282-4 · Cited by 48
Cerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism
Lin, X., Ullah, M. H. E., Xiong, W., Xu, F., Shan, S., Lei, L.-M., Yuan, L., & Liu, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.798364 · Cited by 45
Ambrosino, P., Lupoli, R., Tortora, A., Cacciapuoti, M., Lupoli, G., Tarantino, P., Nasto, A., & Minno, M. N. D. D. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.01.200 · Cited by 41
Smooth muscle mineralocorticoid receptor as an epigenetic regulator of vascular ageing
Ibarrola, J., Kim, S. K., Lu, Q. R., DuPont, J. J., Creech, A. L., Sun, Z., Hill, M. A., Jaffe, J. D., & Jaffe, I. Z. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac007 · Cited by 38
Cooper, J. N., Tepper, P. G., Barinas‐Mitchell, E., Woodard, G. A., & Sutton-Tyrrell, K. (2011) · Clinical and Experimental Hypertension · doi:10.3109/10641963.2011.618200 · Cited by 38
Aldosteronism and Resistant Hypertension
Acelajado, M. C., & Calhoun, D. A. (2011) · International Journal of Hypertension · doi:10.4061/2011/837817 · Cited by 39
Aldosterone Induces Vascular Damage
Hung, C., Sung, S., Liao, C., Pan, C., Chang, C., Chen, Z., Wu, V., Chen, C., Cheng, H., Lin, Y., et al. (2019) · Hypertension · doi:10.1161/hypertensionaha.118.12342 · Cited by 38
Underdiagnosis of Primary Aldosteronism: A Review of Screening and Detection
Hernandez, M. F., & Bhalla, V. (2023) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2023.01.447 · Cited by 36
Tsai, C., Liao, C., Wu, X.-M., Chen, Z., Pan, C., Chang, Y., Lee, B., Shun, C., Wen, W.-F., Chou, C., et al. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-1157 · Cited by 36
Low dose‐eplerenone treatment decreases aortic stiffness in patients with resistant hypertension
Kalizki, T., Schmidt, B. M. W., Raff, U., Reinold, A., Schwarz, T., Schneider, M. P., Schmieder, R. E., & Schneider, A. (2017) · Journal of Clinical Hypertension · doi:10.1111/jch.12986 · Cited by 35
The management of aldosterone-producing adrenal adenomas—does adrenalectomy increase costs?
Reimel, B., Zanocco, K. A., Russo, M. J., Zarnegar, R., Clark, O. H., Allendorf, J., Chabot, J. A., Duh, Q., Lee, J. A., & Sturgeon, C. (2010) · Surgery · doi:10.1016/j.surg.2010.09.012 · Cited by 34
Vascular Disturbances in Primary Aldosteronism: Clinical Evidence
Widimsky, J., Jr., Štrauch, B., Petrák, O., Rosa, J., Šomlóová, Z., Zelinka, T., & Holaj, R. (2012) · Kidney & Blood Pressure Research · doi:10.1159/000340031 · Cited by 34
Impact of Fibroblast Growth Factor 23 on Lipids and Atherosclerosis in Hemodialysis Patients
Ashikaga, E., Honda, H., Suzuki, H., Hosaka, N., Hirai, Y., Sanada, D., Nakamura, M., Nagai, H., Matsumoto, K., Kato, N., et al. (2010) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2009.00796.x · Cited by 34
Primary Aldosteronism and Cerebrovascular Diseases
Chen, Z.-W., Hung, C., Wu, V.-C., & Lin, Y.-H. (2018) · Endocrinology and Metabolism · doi:10.3803/enm.2018.33.4.429 · Cited by 25
Treatment of primary aldosteronism
Quinkler, M. O., & Stewart, P. M. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.10.001 · Cited by 35
Aldosterone Impairs Vascular Smooth Muscle Function: From Clinical to Bench Research
Chou, C., Chen, Y.-H., Hung, C., Chang, Y., Tzeng, Y.-L., Wu, X.-M., Wu, V., Tsai, C., Wu, C., Ho, Y., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2752 · Cited by 31
Burrello, J., Gai, C., Tetti, M., Lopatina, T., Deregibus, M. C., Veglio, F., Mulatero, P., Camussi, G., & Monticone, S. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.12944 · Cited by 30
Primary aldosteronism: emerging trends
Galati, S.-J., Hopkins, S. M., Cheesman, K. C., Zhuk, R. A., & Levine, A. C. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.05.003 · Cited by 31
Therapeutic Outcomes with Surgical and Medical Management of Primary Aldosteronism
Wachtel, H., & Fraker, D. L. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01516-0 · Cited by 29
Liao, C., Lin, L., Hung, C., Lin, Y.-T., Chang, Y., Wang, S., Wu, V., Wu, K., Ho, Y., Satoh, F., et al. (2016) · Scientific Reports · doi:10.1038/srep20862 · Cited by 29
Peripheral Arterial Stiffness in Primary Aldosteronism
Rosa, J., Šomlóová, Z., Petrák, O., Štrauch, B., Indra, T., Šenitko, M., Zelinka, T., Holaj, R., & Widimsky, J., Jr. (2012) · Physiological Research · doi:10.33549/physiolres.932344 · Cited by 31
Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism
Huang, K., Yu, C., Hu, Y., Chang, C., Chan, C., Liao, S., Tsai, Y., Chueh, S., Wu, V., Lin, Y., et al. (2018) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.01.006 · Cited by 26
Aldosterone, inactive matrix gla-protein, and large artery stiffness in hypertension
Chirinos, J. A., Sardana, M., Syed, A. A., Koppula, M. R., Varakantam, S., Vasim, I., Oldland, H. G., Phan, T. S., Drummen, N. E. A., Vermeer, C., et al. (2018) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2018.06.018 · Cited by 26
Choudhary, M. K., Värri, E. K. H., Matikainen, N., Koskela, J., Tikkakoski, A., Kähönen, M. A. P., Niemelä, O. J., Mustonen, J. T., Nevalainen, P. I., & Pörsti, I. H. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13115 · Cited by 25
Billmann, F. G., Billeter, A. T., Thomusch, O., Keck, T., Shishtawi, S. E., Langan, E. A., Strobel, O., & Müller-Stich, B. P. (2020) · Surgery · doi:10.1016/j.surg.2020.09.005 · Cited by 24
Thiesmeyer, J. W., Ullmann, T. M., Stamatiou, A. T., Limberg, J. N., Stefanova, D. I., Beninato, T. M., Finnerty, B. M., Vignaud, T., Leclerc, J., Fahey, T. J., et al. (2020) · JAMA Surgery · doi:10.1001/jamasurg.2020.5011 · Cited by 24
Chen, Z., Pan, C., Liao, C., Tsai, C., Chang, Y., Chang, C., Lee, B., Chiu, Y., Huang, W., Wang, S., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac649 · Cited by 23
Hipertensión por hiperaldosteronismo: más lesión cardiaca, mayor riesgo cardiovascular
Abad-Cardiel, M., Álvarez-Álvarez, B., Luque-Fernandez, L., Fernández, C., Fernández‐Cruz, A., & Claros, N. M. (2012) · Revista Española de Cardiología · doi:10.1016/j.recesp.2012.07.025 · Cited by 23
Demirkıran, A., Everaars, H., Elitok, A., van de Ven, P. M., Smulders, Y. M., Dreijerink, K. M. A., Tanakol, R., & Özcan, M. (2019) · Journal of Clinical Hypertension · doi:10.1111/jch.13585 · Cited by 23
Burrello, J., Tetti, M., Forestiero, V., Biemmi, V., Bolis, S., Pomatto, M. A. C., Amongero, M., Silvestre, D. D., Mauri, P., Vassalli, G., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17136 · Cited by 22
Eplerenone improves carotid intima-media thickness (IMT) in patients with primary aldosteronism
Matsuda, Y., Kawate, H., Matsuzaki, C., Sakamoto, R., Shibue, K., Ohnaka, K., Anzai, K., Nomura, M., & Takayanagi, R. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej15-0362 · Cited by 22
Yan, Y., Wang, C., Lu, Y., Gong, H., Wu, Z., Ma, X., Li, H., Wang, B., & Zhang, X. (2017) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-017-0600-2 · Cited by 22
Kishimoto, S., Oki, K., Maruhashi, T., Kajikawa, M., Matsui, S., Hashimoto, H., Takaeko, Y., Kihara, Y., Chayama, K., Goto, C., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001989 · Cited by 20
Hypertension Caused by Primary Hyperaldosteronism: Increased Heart Damage and Cardiovascular Risk
Abad-Cardiel, M., Álvarez-Álvarez, B., Luque-Fernandez, L., Fernández, C., Fernández‐Cruz, A., & Claros, N. M. (2012) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2012.07.017 · Cited by 20
Nayak, S. S., Amini‐Salehi, E., Joukar, F., Biswas, P., Nobakht, S., Letafatkar, N., Porteghali, P., Mohammadi‐Vajari, E., Mansour‐Ghanaei, F., Javid, M., et al. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000002048 · Cited by 18
Chan, C., Yang, W., Lin, Y., Huang, K., Lu, C., Hu, Y., Wu, V., Chueh, S., Chu, T., & Chen, Y. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa566 · Cited by 18
Galati, S.-J. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.010 · Cited by 18
Diagnosis and Management of Primary Aldosteronism
Wu, V., Chao, C., Kuo, C., Lin, Y., Chueh, S., & Wu, K. (2012) · Acta Nephrologica · doi:10.6221/an.2012005 · Cited by 17
Chan, C., Kim, J. H., Chueh, E., Chang, C., Lin, Y., Lai, T., Huang, K., Lin, Y., & Wu, V. (2019) · Surgery · doi:10.1016/j.surg.2019.05.001 · Cited by 17
Mark, P. B., Boyle, S., Zimmerli, L., McQuarrie, E. P., Delles, C., & Freel, E. M. (2013) · Journal of Human Hypertension · doi:10.1038/jhh.2013.70 · Cited by 17
Bollati, M., Lopez, C., Bioletto, F., Ponzetto, F., Ghigo, E., Maccario, M., & Parasiliti‐Caprino, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042111 · Cited by 16
Mineralocorticoid Receptor Antagonists in Primary Aldosteronism
Stavropoulos, K., Papadopoulos, C. E., Koutsampasopoulos, K., Lales, G., Mitas, C., & Doumas, M. N. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190311130138 · Cited by 16
Fujita, N., Hatakeyama, S., Yamamoto, H., Tobisawa, Y., Yoneyama, T., Yoneyama, T., Hashimoto, Y., Koie, T., Nigawara, T., & Οhyama, C. (2016) · International Journal of Urology · doi:10.1111/iju.13060 · Cited by 15
Varano, M., Iacono, P., Tedeschi, M., Letizia, C., Curione, M., Savoriti, C., Baiocco, E., Zinnamosca, L., Marinelli, C., Boccassini, B., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02622-2 · Cited by 14
The Renaissance of Primary Aldosteronism: What Has it Taught Us?
Stowasser, M., & Gordon, R. D. (2013) · Heart Lung and Circulation · doi:10.1016/j.hlc.2013.01.006 · Cited by 14
Gan, L., Li, N., Heizhati, M., Lin, M., Zhu, Q., Yao, X., Wu, T., Wang, M., Luo, Q., Zhang, D., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1017177 · Cited by 13
Tseng, C., Chan, C., Lee, H.-Y., Pan, C., Peng, K., Wang, S., Huang, K., Tsai, Y., Wu, V., & Chueh, S. (2023) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2023.05.032 · Cited by 13
Risk of ischemic stroke in primary aldosteronism patients.
Kao, C., Wu, C.-H., Lin, Y.-H., Chang, C.-C., Chen, H.-H., Wu, M.-S., Wu, V., & Wu, K.-D. (2015) · Clinica chimica acta; international journal of clinical chemistry · doi:10.1016/j.cca.2014.08.007 · Cited by 14
Leung, H., Woo, Y. C., Fong, C. H.-Y., Tan, K. C. B., Lau, E., Chan, K. W., & Leung, J. Y. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01114-6 · Cited by 13
Clinical presentation and surgical outcomes in primary aldosteronism differ by race
Gershuni, V. M., Ermer, J. P., Kelz, R. R., Roses, R. E., Cohen, D. L., Trerotola, S. O., Fraker, D. L., & Wachtel, H. (2019) · Journal of Surgical Oncology · doi:10.1002/jso.25806 · Cited by 12
Treatment of primary aldosteronism: Where are we now?
Karagiannis, A. I. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9159-3 · Cited by 12
Thiesmeyer, J. W., Ullmann, T. M., Greenberg, J. A., Williams, N., Limberg, J. N., Stefanova, D. I., Beninato, T. M., Finnerty, B. M., Vignaud, T., Leclerc, J., et al. (2020) · Surgery · doi:10.1016/j.surg.2020.04.017 · Cited by 12
Yan, Y., Sun, H., & Qi, Y. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14395 · Cited by 11
Difficult-to-Treat or Resistant Hypertension: Etiology, Pathophysiology, and Innovative Therapies
Papademetriou, V., Tsioufis, C. P., Gradman, A. H., & Punzi, H. A. (2011) · International Journal of Hypertension · doi:10.4061/2011/438198 · Cited by 11
Aldosterone, mitochondria and regulation of cardiovascular metabolic disease
Tsai, C., Chen, Z., Lee, B., Liao, C., Chang, Y., Tsai, Y.-R., Chou, C., Wu, V., Hung, C., & Lin, Y. (2024) · Journal of Endocrinology · doi:10.1530/joe-23-0350 · Cited by 11
Lottspeich, C., Köhler, A., Czihal, M., Heinrich, D. A., Schneider, H., Handgriff, L., Reincke, M., & Adolf, C. (2021) · Hormone and Metabolic Research · doi:10.1055/a-1326-2164 · Cited by 10
Diagnosing and Managing Primary Aldosteronism in Hypertensive Patients: a Case-Based Approach
Carey, R. M. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0774-1 · Cited by 9
Circadian hemodynamic characteristics in hypertensive patients with primary aldosteronism
Kusunoki, H., Iwashima, Y., Kawano, Y., Hayashi, S.-I., Kishida, M., Horio, T., Shinmura, K., & Yoshihara, F. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001800 · Cited by 9
Tsai, C., Wu, X.-M., Liao, C., Chen, Z., Pan, C., Chang, Y., Lee, B., Chiu, Y., Lai, T., Wu, V., et al. (2022) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223211066727 · Cited by 9
Kuo, C., Balakrishnan, P., Hsein, Y.-C., Wu, V., Chueh, S., Chen, Y.-M., Wu, K., Wang, M., TAIPAI group, Wu, V., et al. (2014) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320313498632 · Cited by 9
Then, C., Rottenkolber, M., Lechner, A., Meisinger, C., Heier, M., Köenig, W., Peters, A., Rathmann, W., Bidlingmaier, M., Reincke, M., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.07.905 · Cited by 8
Crilly, M., & Mangoni, A. A. (2011) · BMJ Open · doi:10.1136/bmjopen-2011-000076 · Cited by 8
Clinical Characteristics and Long-Term Outcome of Primary Aldosteronism in a Norwegian Population
Grytaas, M. A., Strømsøy, S., Rørvik, J. T., Arnes, J. B., Heie, A., Arnesen, T., Jørstad, M. D., Nedrebø, B. G., Jøssang, D. E., Jensen, D., et al. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-118909 · Cited by 7
Genetic aspects of primary hyperaldosteronism
Korzyńska, W., Jodkowska, A., Gosławska, K., Bogunia‐Kubik, K., & Mazur, G. J. (2018) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/69390 · Cited by 8
Zhou, P., Cai, X., Song, S., Hu, J., Zhu, Q., Ma, H., Zhang, Y., Ma, R., Shen, D., Yang, W., et al. (2025) · Postgraduate Medicine · doi:10.1080/00325481.2025.2460417 · Cited by 7
Chen, Z., Pan, C., Tsai, C., Chang, Y., Chang, C., Lee, B., Chiu, Y., Huang, W., Lin, Y., Wu, V., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9101285 · Cited by 7
Impact of Primary Aldosteronism in Resistant Hypertension
Stavropoulos, K., Imprialos, K. P., Patoulias, D., Katsimardou, A., & Doumas, M. N. (2022) · Current Hypertension Reports · doi:10.1007/s11906-022-01190-9 · Cited by 6
Liao, C., Lin, Y.-T., Tsai, C., Chang, Y., Chen, Z., Lu, C., Pan, C., Chang, C., Lee, B., Chiu, Y., et al. (2023) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223221143233 · Cited by 5
Jiang, Y., Zhou, L., Zhang, C., Su, T., Jiang, L., Zhou, W., Zhong, X., Wu, L., & Wang, W. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.09.002 · Cited by 5
Buonacera, A., Stancanelli, B., & Malatino, L. (2017) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-017-0200-9 · Cited by 5
Yamashita, K., Morimoto, S., Seki, Y., Watanabe, D., & Ichihara, A. (2019) · Hypertension Research · doi:10.1038/s41440-019-0312-9 · Cited by 5
Bouhanick, B., Amar, J., Amar, L., Gosse, P., Girerd, X. J., Reznik, Y., Mounier‐Véhier, C., Baguet, J.-P., Boutouyrie, P., Lepage, B., et al. (2018) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2018.01.004 · Cited by 5
Metadata
- Authors
- Bernini, G., Galetta, F., Franzoni, F., Bardini, M., Taurino, C., Bernardini, M., Ghiadoni, L., Bernini, M., Santoro, G., & Salvetti, A.
- Affiliations
- University of Pisa (IT)
- Corresponding author
- Bernini, Giampaolo
- Bernini, Matteo
- Venue
- Journal of Hypertension
- Published
- 2008-12
- Volume
- 26
- Issue
- 12
- Pages
- 2399-2405
- ISSN
- 0263-6352 (ISSN-L)
- OpenAlex
- W1985050616
- Cited by
- 136
- References
- 40
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 8 · 2023: 4 · 2022: 15 · 2021: 5 · 2020: 11 · 2019: 9 · 2018: 16 · 2017: 9 · 2016: 11 · 2015: 6 · 2014: 4 · 2013: 9 · 2012: 9
- FWCI
- 3.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hypertension (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Nephrology › Renal and Vascular Pathologies
- Keywords
- primary aldosteronism, arterial stiffness, intima-media thickness, carotid intima-media thickness, integrated backscatter, pulse wave velocity, aortic augmentation index, essential hypertension, vascular wall structure, applanation tonometry, carotid ultrasound, tissue characterization, cardiovascular risk stratification, renin-angiotensin system
- MeSH terms
- Aorta, Carotid Arteries, Elasticity, Female, Femoral Artery, Fibrosis, Humans, Hyperaldosteronism, Hypertension, Male, Middle Aged, Pulsatile Flow, Regional Blood Flow, Ultrasonography, Case-Control Studies, Radial Artery, Tunica Intima, Tunica Media
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review